Skip to main content

Month: July 2020

Koss® Corporation Announces Second Phase of Intellectual Property Enforcement Program

MILWAUKEE, Wis., July 23, 2020 (GLOBE NEWSWIRE) — Koss® Corporation (NASDAQ Symbol: KOSS), the U.S. based high-fidelity Stereophone manufacturer and inventor of the world’s first SP/3 Stereophone in 1958, announced the next phase of the company’s intellectual property enforcement program.“Koss has taken deliberate action and filed multiple complaints in United States District Court against multiple companies that we believe are engaging in the willful infringement of several Koss patents,” said Michael J. Koss, Jr., Vice President – Marketing & Product.The Koss patents in this enforcement action date back to the mid-2000s when Koss began investing heavily in developing and inventing truly wireless headphones capable of operating as bidirectional endpoints, the company called this project “Striva”. Many of the features of the...

Continue reading

NaturalShrimp, Inc. to Expand Production Facilities at Texas Plant Location

Dallas, Texas, July 23, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NaturalShrimp, Inc. (OTCQB: SHMP), the aquaculture company that has developed and patented the first commercially-operational RAS (Recirculating Aquaculture System) for shrimp, announced today it plans to build an adjacent 40,000 square foot production facility (Site 2), at the La Coste site in Texas.This facility will mirror the existing site currently under construction. The current site will consist of a 40,000 square foot shrimp production building currently under construction that contains twenty (20) 2,000-gallon nursery tanks, forty (40) 20,000-gallon grow out tanks, two (2) 10,000-gallon settling tanks, and one (1) 20,000-gallon harvest tank for a total tank volume capacity of 880,000 gallons. Office suites, a conference room and reception center will...

Continue reading

UPDATE: ECOFIBRE LIMITED – Ananda Health products used in first clinical trial on hemp-derived CBD to treat chemotherapy-induced peripheral neuropathy

Georgetown, Kentucky, July 23, 2020 (GLOBE NEWSWIRE) — Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for Medical Research (LIMR), Wynnewood, Pa., has begun patient enrollment in a phase II clinical trial using Ananda Health hemp-derived cannabidiol (CBD). The purpose of this study is to assess the efficacy of a hemp-based CBD product, Ananda Health Spectrum gelcaps, on the severity and duration of chemotherapy-induced peripheral neuropathy (CIPN) among breast, colon, and ovarian cancer patients who received common types of neurotoxic chemotherapy. Ecofibre and Ananda demonstrate their commitment to advancing the science of CBD with the launch of the Coala-T-CBD study™ (ClinicalTrials.gov Identifier: NCT04398446). The phase II clinical trial began...

Continue reading

Lakeland Bancorp Announces Second Quarter Results

OAK RIDGE, N.J., July 23, 2020 (GLOBE NEWSWIRE) — Lakeland Bancorp, Inc. (NASDAQ: LBAI) (the “Company”), the parent company of Lakeland Bank (“Lakeland”), reported net income of $11.9 million and earnings per diluted share (“EPS”) of $0.23 for the three months ended June 30, 2020 compared to net income of $17.5 million and diluted EPS of $0.34 for the second quarter of 2019. For the second quarter of 2020, annualized return on average assets was 0.67%, annualized return on average common equity was 6.42% and annualized return on average tangible common equity was 8.19%. For the six months ended June 30, 2020, the Company reported net income of $24.2 million and earnings per diluted share (“EPS”) of $0.47 compared to net income of $33.1 million and diluted EPS of $0.65 for the first six months of 2019. For the first six months of 2020,...

Continue reading

Fortran Corporation Receives Purchase Order From Caldwell County School District for 11 Hikvision Thermal Imaging Temperature Sensing Cameras

Conover, NC, July 23, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Fortran Corporation (OTC: FRTN) a leading telecommunications system integrator and distributor of Hikvision thermal graphic temperature sensing cameras, is pleased to announce B and L Telephone, LLC, one of Fortran’s wholly owned subsidiaries, has received a purchase order for 11 thermal imaging temperature sensing cameras to be installed in certain schools within the Caldwell County school district. These cameras will play an integral part in providing safety measures for faculty, staff, students, and parents for the upcoming school year. In addition, B and L Telephone received a contract for the sale and installation of a Hikvision thermal imaging temperature sensing camera for a local research facility in Hickory, North Carolina. This device will allow the research...

Continue reading

Form 8.3 – HWSI Realisation Fund Limited

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

OptimizeRx Sets Second Quarter 2020 Conference Call for Wednesday, August 5, 2020 at 4:30 p.m. ET

ROCHESTER, Mich., July 23, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, will hold a conference call on Wednesday, August 5, 2020 at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2020. The financial results will be issued in a press release prior to the call.OptimizeRx management will host the call, followed by a question and answer period.Date: Wednesday, August 5, 2020Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number:  1-866-248-8441International dial-in number:  1-323-289-6576Conference ID:  1161129Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting...

Continue reading

Verrica Pharmaceuticals Announces Dr. Lawrence Eichenfield Joins Board of Directors

– Leading pediatric dermatologist brings significant expertise in the treatment of skin diseases to help inform development of the Company’s product candidates –WEST CHESTER, Pa., July 23, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, today announced that Dr. Lawrence Eichenfield, Chief of Pediatric and Adolescent Dermatology, Rady Children’s Hospital, San Diego, CA, is joining the Company’s Board of Directors (the “Board”), effective August 1, 2020. Dr. Eichenfield will replace Dr. Gary Goldenberg who will be stepping down from the Board to assume the role of Verrica’s Chief Medical Officer, which the Company announced separately today.“Dr. Eichenfield’s research has shaped the field...

Continue reading

APPlife Digital Solutions, Inc. Announces Engagement of Investment Banking Firm Carter, Terry & Company

SAN FRANCISCO, July 23, 2020 (GLOBE NEWSWIRE) — APPlife Digital Solutions, Inc. (OTCQB: ALDS) (“APPlife”, the Company”), a business incubator and portfolio manager that invests in and creates e-commerce and cloud-based solutions, announced today that it has retained the services of Atlanta-based investment banking firm Carter, Terry & Company (“Carter, Terry”) to assist in raising new capital, as well as fund the Company’s continuing general operations.  “Engaging Carter, Terry & Company is the next important step in supporting the execution of our business plan, as well as to assist in broadening APPlife’s brand through potential strategic acquisitions and partnerships,” stated Matt Reid, CEO of APPlife.  “Carter, Terry, along with our financial advisory partner Maxim Group, have previously worked simultaneously on a...

Continue reading

WPD Pharmaceuticals Licensor Announces New Independent In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus

VANCOUVER, British Columbia, July 23, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to announce that Moleculin Biotech Inc. (“Moleculin”), the company that sublicenses the compound WP1122 to WPD for 29 countries mainly in Europe, announced that a second round of independent laboratory testing has confirmed the antiviral activity of WP1122 against coronavirus.Moleculin’s July 21, 2020 press release states, “Moleculin contracted with IIT Research Institute (an affiliate of the Illinois Institute of Technology, “IITRI”) for additional in vitro testing of its drug candidate, WP1122, in development as a possible treatment for COVID-19.  The testing involved a cell viability assay in the VERO E6 cell line infected with SARS-CoV-2...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.